InvestorsHub Logo
Followers 84
Posts 1928
Boards Moderated 0
Alias Born 03/05/2014

Re: pearsby09 post# 8428

Tuesday, 12/20/2016 6:51:13 PM

Tuesday, December 20, 2016 6:51:13 PM

Post# of 233040
I agree pearsby09... a huge win. However IMO we need more data to move BP. The 300 patient P3 Mono trial interim data is what BP will pay attention to. That could fully enroll before P3 Adjunct Primary endpoint is achieved meaning that data could be available by the end of Q3 2017.

So far there is nothing that tells me that the data will be anything but disruptive to the HIV space. There is a tipping point in here somewhere in terms of data - wish I had a crystal ball, so instead I will hurry up and wait.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News